1. Clinical, radiological and genetic characterization of PLA2G6-associated neurodegeneration. (June 2017) Authors: Darling, A.; Aguilera Albesa, S.; Tomás Vila, M.; Camino León, R.; Fernández Ramos, J.; Jimenez Escrig, A.; O'Callaghan, M.; Ortez, C.; Nascimento, A.; Candau Fernández Mesaque, R.; Madruga, M.; Arrabal, L.; Roldan, S.; Garrido, C.; Tello, C.A.; Lupo, V.; Huisman, T.A.G.M.; Poretti, A.; Espinós, ... Journal: European journal of paediatric neurology Issue: Volume 21(2017)Supplement 1 Page Start: e176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Early toxicity outcomes: A single 15Gy fraction HDR brachytherapy as pre-treatment EBRT boost in prostate cancer. (April 2015) Authors: Chicas Sett, R.; Soler, A.; Fernandez, J.; Burgos, J.; Pons, O.; Roldan, S.; Celada, F.; Gimeno, J.; Tormo, A.; Perez-Calatayud, J. Journal: Radiotherapy and oncology Issue: Volume 115(2015)Supplement 1 Page Start: V Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EP-1256: Salvage iodine-125 brachytherapy for local prostate cancer recurrence after radiotherapy. (April 2015) Authors: Celada, F.; Chicas, R.; Soler, A.; Roldan, S.; Candela, C.; Gimeno, J.; Tormo, A.; Perez-Calatayud, J. Journal: Radiotherapy and oncology Issue: Volume 115(2015)Supplement 1 Page Start: S679 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PO-0723: Early toxicity outcomes: A single 15Gy fraction HDR brachytherapy as pre-treatment EBRT boost in prostate cancer. (April 2015) Authors: Chicas Sett, R.; Soler, A.; Fernandez, J.; Burgos, J.; Pons, O.; Roldan, S.; Celada, F.; Gimeno, J.; Tormo, A.; Perez-Calatayud, J. Journal: Radiotherapy and oncology Issue: Volume 115(2015)Supplement 1 Page Start: S357 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PO-0726: Dose escalation with HDR brachytherapy for intermediate- and high-risk prostate cancer. (May 2017) Authors: Chicas-Sett, R.; Celada, F.; Burgos, J.; Farga, D.; Perez-Calatayud, M.; Roldan, S.; Collado, E.; Ibañez, B.; Perez-Calatayud, J.; Tormo, A. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S380 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗